156 related articles for article (PubMed ID: 16947320)
1. Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia.
Saito B; Nakamaki T; Nakashima H; Usui T; Hattori N; Kawakami K; Tomoyasu S
Am J Hematol; 2007 Apr; 82(4):304-6. PubMed ID: 16947320
[TBL] [Abstract][Full Text] [Related]
2. [Successful recovery of an acute myelogenous leukemia patient from a coma possibly due to leukoencephalopathy].
Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
Rinsho Ketsueki; 2003 Nov; 44(11):1090-4. PubMed ID: 14689873
[TBL] [Abstract][Full Text] [Related]
3. [Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase].
Miyazawa Y; Irisawa H; Matsushima T; Mitsui T; Uchiumi H; Saitohi T; Handa H; Karasawa M; Murakami H; Tsukamoto N; Nojima Y
Rinsho Ketsueki; 2006 Jun; 47(6):531-5. PubMed ID: 16862982
[TBL] [Abstract][Full Text] [Related]
4. [Reversible posterior leukoencephalopathy in a patient receiving cyclosporin therapy].
Nishigaki Y; Inoue M; Jimi T; Wakayama Y; Yoshiba M
Rinsho Shinkeigaku; 1999; 39(2-3):360-3. PubMed ID: 10391082
[TBL] [Abstract][Full Text] [Related]
5. [A 45-year-old man with peripheral monocytosis and right hemiparesis].
Takubo H; Hattori N; Irie S; Mizutani Y; Mori H; Suda K; Kondo T; Oshimi K; Mizuno Y
No To Shinkei; 1998 May; 50(5):481-9. PubMed ID: 9621375
[TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].
Koh H; Yamane T; Nakane T; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Nakamae H; Koh KR; Mochizuki K; Hayashi N; Hino M
Rinsho Ketsueki; 2006 Dec; 47(12):1539-43. PubMed ID: 17233473
[TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
[TBL] [Abstract][Full Text] [Related]
8. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
[No Abstract] [Full Text] [Related]
9. Conventional and diffusion-weighted MRI findings of methotrexate related sub-acute neurotoxicity.
Balin J; Parmar H; Kujawski L
J Neurol Sci; 2008 Jun; 269(1-2):169-71. PubMed ID: 18191947
[TBL] [Abstract][Full Text] [Related]
10. [A reversible posterior leukoencephalopathy syndrome in a patient with classical polyarteritis nodosa].
Arai M; Shigeno K; Wada M
Rinsho Shinkeigaku; 1997 Jan; 37(1):64-6. PubMed ID: 9146079
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced acral erythema in a pediatric patient with acute monoblastic leukemia.
Demircioğlu F; Oren H; Yilmaz S; Arslansoyu S; Eren S; Irken G
Pediatr Hematol Oncol; 2008; 25(3):211-5. PubMed ID: 18432504
[TBL] [Abstract][Full Text] [Related]
12. Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.
Tam CS; Galanos J; Seymour JF; Pitman AG; Stark RJ; Prince HM
Am J Hematol; 2004 Sep; 77(1):72-6. PubMed ID: 15307110
[TBL] [Abstract][Full Text] [Related]
13. Reversible posterior leukoencephalopathy syndrome caused by blood transfusion: a case report.
Huang YC; Tsai PL; Yeh JH; Chen WH
Acta Neurol Taiwan; 2008 Dec; 17(4):258-62. PubMed ID: 19280871
[TBL] [Abstract][Full Text] [Related]
14. [A case of brainstem variant of reversible posterior leukoencephalopathy syndrome].
Kawabori M; Murata J; Abe S; Saito H
No Shinkei Geka; 2009 Nov; 37(11):1105-9. PubMed ID: 19938667
[TBL] [Abstract][Full Text] [Related]
15. [Posterior reversible encephalopathy syndrome following acute pancreatitis during chemotherapy for acute monocytic leukemia].
Nishimoto M; Koh H; Bingo M; Yoshida M; Nanno S; Hayashi Y; Nakane T; Nakamae H; Shimono T; Hino M
Rinsho Ketsueki; 2014 May; 55(5):552-7. PubMed ID: 24881921
[TBL] [Abstract][Full Text] [Related]
16. [Acute monoblastic leukemia complicated by fatal splenic rupture following initiation of chemotherapy].
Borgeat A; Tran-Thang C; Bachmann F
Schweiz Med Wochenschr; 1989 Feb; 119(7):227-9. PubMed ID: 2711160
[TBL] [Abstract][Full Text] [Related]
17. Brachial plexus neuropathy following high-dose cytarabine in acute monoblastic leukemia.
Scherokman B; Filling-Katz MR; Tell D
Cancer Treat Rep; 1985 Sep; 69(9):1005-6. PubMed ID: 2992782
[TBL] [Abstract][Full Text] [Related]
18. Cytarabine-induced cerebellar syndrome: case report and literature review.
Sylvester RK; Fisher AJ; Lobell M
Drug Intell Clin Pharm; 1987 Feb; 21(2):177-80. PubMed ID: 3470173
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study.
Kim H; Park JH; Lee JH; Lee JH; Joo YD; Lee WS; Bae SH; Mo Ryoo H; Lee KH;
Am J Hematol; 2009 Mar; 84(3):161-6. PubMed ID: 19195034
[TBL] [Abstract][Full Text] [Related]
20. Severe central nervous system toxicity from high-dose cytarabine: expressive aphasia occurring after the second day of treatment.
Watson PR; Brubaker LH; Yaghmai F
Cancer Treat Rep; 1985 Mar; 69(3):313-4. PubMed ID: 3978659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
